Adaptimmune Therapeutics PLC (NASDAQ:ADAP) Q4 2020 Earnings Conference Call February 25, 2020 8:00 AM ET Company Participants Juli Miller - Senior Director, IR Adrian Rawcliffe - CEO Elliot Norry - Senior VP and Chief Medical Officer Helen Tayton-Martin - Co-Founder and Chief Business Officer Conference Call Participants Tony Butler - ROTH Capital Kenneth Atkins - Cowen & Company Mohit Bansal - Citi Group Michael Smith - Guggenheim Nick Abbott - Wells Fargo Operator Ladies and gentlemen, thank you for stand ...